COVID-19 Pneumonia

Infectious Disease·MeSH: COVID-19

Prevalence

10000.0 / 100K

Incidence

5000.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target COVID-19 Pneumonia?

There are 1 clinical trial targeting COVID-19 Pneumonia tracked by BioSniper.

What is the prevalence of COVID-19 Pneumonia?

The estimated prevalence of COVID-19 Pneumonia is approximately 10000.0 per 100,000 population.

Deep-dive into COVID-19 Pneumonia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    COVID-19 Pneumonia — Drugs in Development & Clinical Trials | BioSniper